Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
ASCP Corner
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Jun Zhao, PhD
JCP
Original Research
ABT-126 for Cognitive Impairment in Schizophrenia
September 12, 2017
Cognitive impairment often limits the ability of patients with schizophrenia to function in the community, but no medications are approved to treat this impairment. Read this article to learn...
George M. Haig
,
Deli Wang
,
Jun Zhao
, et al
JCP
Original Research
Effects of Asenapine in Bipolar I Patients Meeting Proxy Criteria for Moderate-to-Severe Mixed Major Depressive Episodes: A Post Hoc Analysis
June 24, 2015
Michael Berk
,
John W. G. Tiller
,
Jun Zhao
, et al
JCP
Original Research
Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder
December 24, 2013
David E. Kemp
,
Jun Zhao
,
Pilar Cazorla
, et al
JCP
Original Research
A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
February 22, 2011
John M. Kane
,
Mary Mackle
,
Linda Snow-Adami
, et al
